Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Morley

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Cellular Signalling|June 5, 2003
Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38Simon J Morley, Susanne Naegele
Developmental Cell|November 13, 2008
Signaling pathways open the GAITway to translational controlSimon J Morley, Mark Willett
The Journal of Biological Chemistry|July 26, 2002
Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cellsSimon J Morley, Susanne Naegele
Molecular Cell|September 1, 2009
Kinky binding and SECsy insertionsSimon J Morley, Mark Willett
The Journal of Biological Chemistry|August 5, 2004
Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stressSusanne Naegele, Simon J Morley
Science Signaling|June 26, 2008
An alternative mechanism of eukaryotic translation initiationSimon J Morley, Mark J Coldwell
The Biochemical Journal|March 10, 2007
Nutrient-responsive mTOR signalling grows on Sterile groundSimon J Cook, Simon J Morley
European Journal of Biochemistry|August 20, 2004
The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complexJoanne L Cowan, Simon J Morley
Molecular and Cellular Biology|September 20, 2006
Specific isoforms of translation initiation factor 4GI show differences in translational activityMark J Coldwell, Simon J Morley
Future Medicinal Chemistry|August 26, 2017
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancersElla Lineham, John Spencer, Simon J Morley
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cellular Signalling|June 5, 2003
Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38Simon J Morley, Susanne Naegele
Developmental Cell|November 13, 2008
Signaling pathways open the GAITway to translational controlSimon J Morley, Mark Willett
The Journal of Biological Chemistry|July 26, 2002
Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cellsSimon J Morley, Susanne Naegele
Molecular Cell|September 1, 2009
Kinky binding and SECsy insertionsSimon J Morley, Mark Willett
The Journal of Biological Chemistry|August 5, 2004
Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stressSusanne Naegele, Simon J Morley
Science Signaling|June 26, 2008
An alternative mechanism of eukaryotic translation initiationSimon J Morley, Mark J Coldwell
The Biochemical Journal|March 10, 2007
Nutrient-responsive mTOR signalling grows on Sterile groundSimon J Cook, Simon J Morley
European Journal of Biochemistry|August 20, 2004
The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complexJoanne L Cowan, Simon J Morley
Molecular and Cellular Biology|September 20, 2006
Specific isoforms of translation initiation factor 4GI show differences in translational activityMark J Coldwell, Simon J Morley
Future Medicinal Chemistry|August 26, 2017
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancersElla Lineham, John Spencer, Simon J Morley
Pageof 5